Skip to main content
AVAI logo

AVAI · Avai Bio, Inc. · Financials

Track AVAI — free
$0.10 0.00 (-1.85%) At close · Oct 22
Market Cap
$15.39M
Shares
153.92M
Volume · Oct 22 52.85K Avg daily vol (3M) 101.4K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$276.32K
FY2023
Net Income
-$1.75M -53.2%
FY2026 Net Income FY2019–FY2026
Gross Margin
-14.64%
FY2023
Operating Margin
-126.28%
FY2023
Operating Cash Flow
-$1.01M +13%
FY2026 Operating Cash Flow FY2019–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
— — — — $276.32K — — — —
— — — — $276.32K $921.31K $1.21M $717.45K —
— — — — — — — $717.45K $0
— — — — $276.32K $710.51K $1.23M $461.12K $0
— — — — -$40.45K -$210.79K -$16.54K -$256.33K $0
— — — — -14.64% — — — —
— $15K — — — — — $27.04K $0
$754.86K $792.27K $762.48K $1.42M $234.91K $449.36K $205.3K $229.35K $38.99K
$24.8K $26.07K $74.32K $76.95K $23.42K — — $39.1K $4802
$1.41M $1.48M $1.53M $2.12M $323.13K $553.92K $287.19K $325.93K $78.23K
-$2.79M -$1.75M -$1.14M -$2.13M -$348.93K $126.52K $302.29K $69.59K -$78.23K
— — — — -126.28% — — — —
-$2.76M -$1.72M -$1.07M -$2.05M -$325.52K — — $108.7K -$73.42K
— — — -$11.29K $14.65K — — — —
— — — — — — — — -$78.23K
-$2.79M -$1.75M -$1.14M -$2.13M -$348.93K -$126.52K -$302.29K -$69.59K -$78.23K
— — — — -126.28% — — — —
-$1.81M -$1.75M -$1.14M — — -$126.52K -$302.29K — —
— — -$1.14M -$2.13M -$351.9K — — — —
USD/shares -$0.01 -$0.01 -$0.01 -$0.02 $0.00 $0.00 $0.00 — —
shares — 137.97M 128.15M 86.53M 38.5M 26.32M 26.28M 1.02M —
shares — — — — — — 26.28M 1.02M 4.64M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of convertible notes payable 2026-06-30 USD 725,138 10-Q filed 2026-08-13
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.93×
EV/EBIT
—
Peer median 9.48×
P/E (TTM)
—
Peer median 18.85×

Peer medians compare against the 88 similar-size Software - Application companies (of 232 listed).

Key facts CIK 1740797 CUSIP 89487B100 Visit website Investor relations